PROZ may serve as a prognostic biomarker for early hepatocellular carcinoma
International Journal of General Medicine Aug 10, 2021
Jiang X, Song T, Pan X, et al. - Protein Z, a vitamin K-dependent plasma glycoprotein (PROZ), has a significant link with prognosis of early hepatocellular carcinoma (HCC).
A bioinformatic analysis was performed using The Cancer Genome Atlas dataset.
Of 615 differentially expressed genes and 8956 genes in the turquoise module, 508 integrated genes were selected.
A protein–protein interaction network was built.
Top 20 hub genes were unveiled including apolipoprotein A-IV, fibrinogen gamma chain, PROZ, secreted phosphoprotein 24 and fetuin-B.
Reduced expression of PROZ was found in early HCC vs normal liver controls.
Low PROZ expression might cause poor overall survival of early HCC.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries